Evidence map›Paper›PMID 35123446›Full record

ArticleBMC pregnancy and childbirth2022

Prenatal diagnosis of a 46,XY karyotype female fetus with an SRY-associated gonadal dysgenesis, conceived through an intracytoplasmic sperm injection: a case report.

Lidiia Zhytnik, Maire Peters, Kadi Tilk, Tiia Reimand, Piret Ilisson, Tiina Kahre, Ülle Murumets, Aivar Ehrenberg, Eva-Liina Ustav, Neeme Tõnisson and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Lidiia ZhytnikCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia. Lidiia.zhytnik@ut.ee.ORCID http://orcid.org/0000-0003-4682-0402
Maire PetersCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Kadi TilkCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Tiia ReimandDepartment of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.
Piret IlissonDepartment of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.
Tiina KahreDepartment of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.
Ülle MurumetsDepartment of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.
Aivar EhrenbergDepartment of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Eva-Liina UstavDepartment of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Neeme TõnissonCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Signe MölderCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Hindrek TederCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Kaarel KrjutškovCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Andres SalumetsCompetence Centre on Health Technologies, Teaduspargi 13, 50411, Tartu, Estonia.
Tartu University Hospital · EECompetence Centre on Health Technologies (Estonia) · EEKarolinska Institutet · SE

Funding

Enterprise Estonia EU48695Estonian Research Competency Council PRG1076Horizon 2020 EU952516
6 · The paper itself

Abstract

backgroundPermanent progression of paternal age and development of reproductive medicine lead to increase in number of children conceived with assisted reproductive techniques (ART). Although it is uncertain if ARTs have direct influence on offspring health, advanced paternal age, associated comorbidities and reduced fertility possess significant risks of genetic disorders to the offspring. With a broad implementation of a non-invasive prenatal testing (NIPT), more cases of genetic disorders, including sex discordance are revealed. Among biological causes of sex discordance are disorders of sexual development, majority of which are associated with the SRY gene. CASE PRESENTATION: We report a case of a non-invasive prenatal testing and ultrasound sex discordance in a 46,XY karyotype female fetus with an SRY pathogenic variant, who was conceived through an intracytoplasmic sperm injection (ICSI) due to severe oligozoospermia of the father. Advanced mean age of ICSI patients is associated with risk of de novo mutations and monogenic disorders in the offspring. Additionally, ICSI patients have higher risk to harbour infertility-predisposing mutations, including mutations in the SRY gene. These familial and de novo genetic factors predispose ICSI-conceived children to congenital malformations and might negatively affect reproductive health of ICSI-patients' offspring.

conclusionsOligozoospermic patients planning assisted reproduction are warranted to undergo genetic counselling and testing for possible inherited and mosaic mutations, and risk factors for de novo mutations.

Indexed as

Genes, sryFemaleFetal DiseasesGonadal Dysgenesis, 46,XYHumansKaryotypingNoninvasive Prenatal TestingParentsRisk FactorsSperm Injections, IntracytoplasmicICSINIPToligozoospermiaprenatal diagnosissexual development disordersSRY

Identifiers

PMID35123446
PMCPMC8818175
OpenAlexW4210510387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.